Bill has supported more than 20 pharma and biotech product launches worldwide while helping numerous in-line brands broaden their industry impact.

Bill is the chairperson of ZS’s shareholders’ council. He is also the global head of biopharma. In this role, he helps shape ZS’s perspective on the future of the industry and supports our engagement with industry executives as we work together to deliver impact to people and patients around the world. Additionally, he is the region managing principal of ZS in East Asia, leading ZS’s people and operations across our locations in China, Japan and Singapore. He serves as a client advisor for global and regional clients based in Europe. Bill’s nearly 20 years at ZS have been split between the U.S. and Switzerland.

Bill’s expertise spans various topics across the pharmaceutical and biotech sector, including asset development and early commercialization, value and access and key account strategy development. His expertise spans the U.S. and key European and global markets based on his experiences working with global headquarters and U.S. affiliate client organizations.

Prior to joining ZS in 2004, Bill was a key account manager and marketing sector leader for BASF in the engineered plastics industry.

Bill holds an MBA from the Kellogg School of Management at Northwestern University. He also holds a B.S. in chemical engineering from the A. James Clark School of Engineering at the University of Maryland.